Forever Labs Competitors and Similar CompaniesClear all
Kronos Bio's competitors and similar companies include Axsome Therapeutics.
 Kronos Bio Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. |  Axsome Therapeutics Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system disorders. | |
Founding Date | Founding Date 2017 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Mateo, US HQ Cambridge, US Cambridge, US | Locations New York, US HQ New York, US |
Employees | Employees 45 | Employees 4111% increase |
Valuation ($) | Valuation ($) 59.1 m | Valuation ($) 4.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $9.8m (FY, 2024) | Revenue (est.) $638.5m (FY, 2025) |
Net income | Net income ($86.1m) (FY, 2024) | Net income ($183.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 271m | Total funding raised $ 7m |
For sources of this data, please see the company profile
View Company Profiles
Axsome Therapeutics
HQ
New York, US
Employees
41↑ 11% increase
Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system disorders.
View company